Geriatrics Flashcards

1
Q

Define delirium

A

An acute fluctuating syndrome of encephalopathy, causing disturbed consciousness, attention, cognition, or perception, usually developing over hours to days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the risk factors for delirium?

A
  • Older age (over 65)
  • Cognitive impairment (e.g. dementia)
  • Frailty/multiple comorbidities
  • Significant injuries (e.g. hip fracture)
  • Functional impairment (e.g. immobility)
  • Iatrogenic events (e.g. surgery, catheterisation, polypharmacy)
  • Substance misuse
  • Hearing or visual impairment
  • Poor nutrition
  • Lack of stimulation or social isolation
  • Terminal phase of illness
  • Movement to a new environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the causes/precipitating factors of delirium?

A

PINCH ME
- Pain (severe, uncontrolled)
- Infection (UTI, pneumonia, sepsis, viral infections, pressure sore)
- Nutrition (inadequate nutrition, vitamin deficiencies)
- Constipation/continence (urinary retention)
- Hydration (dehydration)
- Medications (benzodiazepines, anticholinergics, anticonvulsants, steroids, opioids, anti-Parkinson’s)
- Environment (new, disorientation, sensory impairment, poor sleep)

Others:
- surgery
- toxic substances (alcohol, drug misuse or withdrawal, CO poisoning)
- vascular disorders (stroke, intracranial haemorrhage, vasculitis, cardiac failure or ischemia)
- metabolic (hypoxia, hyponatraemia, hypercalcaemia, hypo/hyperglycaemia, hepatic/renal impairment)
- endocrine (hypo/hyperthyroid, hypo/hyperparathyroid, hypopituitarism, cushing’s)
- neurological (trauma, tumours, epilepsy, cognitive impairment)
- emotional stress/trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical features of delirium?

A
  • Altered cognition: disorientated, memory and language impairment, slow responses, confusion
  • Inattention: worsened concentration, easily distractable, unable to maintain conversations/follow commands
  • Disorganised thinking: rambling or irrelevant conversation, unclear/illogical flow of ideas, difficulty expressing needs
  • Altered perception: paranoid delusions, misperceptions, visual or auditory hallucinations
  • Altered physical function: hyperactive (agitation, restlessness, increased sensitivity), hypoactive (lethargic, reduced mobility/appetite , lack of interest, withdrawn), mixed
  • Altered behaviour: intermittent and liable changes in mood/emotion, non-cooperative or inappropriate behaviour
  • Altered level of consciousness: reduced awareness, sleep disturbances (daytime drowsiness, insomnia, complete sleep cycle reversal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is delirium assessed and investigated?

A
  • Gain collateral history of events and background (will provide onset and details of their baseline cognition)
  • Physical examination: vital signs, and all systems
  • 4AT (four-item test of alertness, cognition, attention, and presence of acute change/fluctuating course)
  • Bloods: FBC, U&E, creatinine, glucose, calcium, magnesium, LFTs, TFTs, vitamin B12, cardiac enzymes, cultures (if indicated)
  • MSU
  • ECG
  • Bladder scan/stool chart (if indicated)
  • CXR (if indicated)
  • Further imaging e.g. head CT (if indicated)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the supportive and environmental managements of delirium?

A

Supportive:
- clear communication (adapted if needed)
- reorientation with reminders of day, time, location, people
- access to familiar objects (especially glasses, hearing aids, mobility aids)
- involvement of family
- consistency of staff
- relaxation

Environmental:
- avoid sensory extremes (over/under stimulation of noise, light, temperature etc.)
- adequate sleep (encourage a normal sleep/wake cycle)
- private space if possible or near to nurses station
- maintain competence e.g. walking
- adequate nutrition (assistance with oral intake, calorie rich foods, monitor weight)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the medical and pharmacological managements of delirium?

A

Medical: (correct underlying precipitants)
- infection (antibiotics)
- constipation (laxatives)
- urinary retention (catheterisation, address any anticholinergics/immobility)
- dehydration and electrolyte abnormalities (monitor fluids, offer oral rehydration, correction of severe electrolyte imbalances)
- pain (regular and adequate analgesia, with careful monitoring with opiates)
- regular medications (consider recent changes)

Pharmacological:
- in patients who are aggressive or not responding to verbal de-escalation techniques (antipsychotics haloperidol or olanzapine may be used at the lowest possible dose for the shortest time)
- in delirium tremens (benzodiazepines diazepam or chlordiazepoxide are used)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define vertigo and its causes

A

The hallucination of movement, and sensation of rotatory motion with respect to the patient and their environment, described as…
- peripheral: problems with the vestibular system, presenting as abrupt onset with nausea/vomiting and tinnitus (e.g. viral labyrinthitis, benign paroxysmal positional vertigo, Meniere’s disease, ototoxicity)
- central: problems with cerebral cortex, cerebellum or brain stem, presenting more gradually with less positional episodes, usually with other neurological signs (acoustic neuroma, stroke, vestibular migraine, MS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define benign paroxysmal positional vertigo

A

Most common cause of vertigo, occurring due to inner ear dysfunction when otoliths become detached from the macula into the semi-circular canals, causing hair cells on the detatched otoliths to be stimulated after the head has stopped moving which gives conflicting sensory inputs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the causes of benign paroxysmal postural vertigo?

A
  • Idiopathic (in 60%)
  • Head injury
  • Spontaneous degeneration of the labyrinth
  • Post-viral illness
  • Complication of stapes surgery
  • Chronic middle ear disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the clinical features of benign paroxysmal positional vertigo?

A
  • Vertigo provoked by head movements (often worse on a particular side)
  • Sudden onset lasting 20-60 seconds, with a 5-20 second delay after the provocative movement
  • Commonly associated with nausea, but not vomiting, tinnitus, hearing loss, or pain
  • May present as a fall or non-specific dizziness in the elderly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What investigations are needed for benign paroxysmal postural vertigo?

A
  • Examination of external ear and tympanic membrane
  • Examine eye movements for nystagmus and saccades
  • Hearing test
  • Neurological examination (e.g. cranial nerves)
  • Hallpike manoeuvre (50-80% sensitive for BPPV)
  • Neuroimaging if any diagnostic uncertainty
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the management of benign paroxysmal positional vertigo?

A
  • General advise: limit symptoms by getting out of bed slowly and reducing head movements
  • Consider safety e.g. driving, occupational hazards, risks of falls
  • Repositing techniques (e.g. Epley’s manoeuvre, or Brandt-Daroff exercises)
  • Avoid vestibular suppressant medications or surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What factors increase the frequency and severity of falls?

A

Frequency:
- intrinsic factors (balance, muscle strength, sensory input, peripheral and central nervous system)
- extrinsic factors (environment, lighting, obstacles, grab rails, height of steps, softness and grip of floor)
- lower threshold of stressors (e.g. pre-existing orthostatic hypotension, syncope)

Severity:
- multiple system impairments (leading to less effective saving mechanisms)
- osteoporosis
- secondary injury due to post-fall immobility (e.g. pressure sores, dehydration, pneumonia)
- psychological adverse effects (e.g. loss of confidence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What medicals conditions associated with falls?

A
  • Affecting mobility, strength or balance (benign paroxysmal positional vertigo, Parkinson’s, orthostatic hypotension, arthritis
  • Affecting cognition: dementia, neurological conditions
  • Affecting sensory elements: visual impairment, peripheral neuropathy
  • Affecting bone health: osteoporosis (increased fracture risk)
  • Leading to urgent movement: urinary frequency, incontinence, infection
  • Cardiac conditions: aortic stenosis, atrial fibrillation, pacemakers, arrhythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What medications are associated with falls?

A
  • Antihypertensives e.g. ramipril, amlodipine (increased risk of hypotension)
  • Sedating drugs e.g. benzodiazepines, antipsychotics, opioids, anti-epileptics (increasing risk of drowsiness causing fall)
  • Diuretics e.g. furosemide, indapamide (increased risk of hypotension and electrolyte disturbances)
  • Antidepressants e.g. SSRIs, TCAs (increased risk of postural hypotension, sedation, and electrolyte disturbances)
  • Skeletal muscle relaxants e.g. baclofen (increased muscle weakness)
  • Diabetic medication e.g. insulin, SGLT2 inhibitors (increased risk of hypoglycaemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What investigations are needed for falls?

A
  • Functional assessment (e.g. stand from chair, walk, turn around)
  • Cardiovascular examination (lying and standing BP, pulse rate and rhythm, murmurs)
  • Neurological examination (identify stroke, Parkinson’s, vestibular disease, cognitive impairment, etc.)
  • Bloods (FBC, B12, folate, U&Es, calcium, phosphate, glucose, TFT)
  • ECG (24hr if patient has frequent near-syncope)
  • Echo (if systolic murmur)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define syncope and presyncope

A
  • Syncope is a sudden transient loss of consciousness due to reduced cerebral perfusion, where the patient is unresponsive and loses postural control (falls)
  • Presyncope is a feeling of light-headedness that would lead to syncope if corrective measures were not taken (e.g. sitting or lying down)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the causes of syncope?

A

Neurally mediated syncope (reflex syncope)…
- vasovagal (simple faint): caused by emotional stress (fear, pain etc.) or orthostatic stress (prolonged standing, crowded, hot places)
- situational syncope: caused by cough, sneeze, GI stimulation, micturition
- carotid sinus hypersensitivity: occurs when rotating head, if collar is tight, if neck tumour present

Orthostatic hypotension (drop of >20 systolic or 10 diastolic within 3 mins of standing) …
- autonomic: Parkinson’s, multi system atrophy, diabetic neuropathy, medications, post-exercise, postprandial
- hypovolaemia: haemorrhage, vomiting, diarrhoea, dehydration, Addison’s disease

Cardiac causes…
- arrhythmias: VT, SVT, fast AF, complete heart block, long QT syndrome
- structural cardiopulmonary causes: acute coronary syndrome, obstructive cardiac valve disease, PE, pulmonary hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the additional features in a history of syncope?

A
  • Was there loss of consciousness? (syncope has brief complete LOC lasting usually under 30 seconds, but may be several minutes)
  • What was the situation? (standing = orthostatic hypotension, exercise = cardiac, in pain/frightened = vasovagal, on the toilet = defecation/micturition syncope)
  • Was there a prodrome? (palpitations = arrhythmia, chest pain or SOB = ischemia, light-headedness = hypotension)
  • Description of the attack from eye witness (pale/clammy = systemic hypoperfusion, ictal features = seizure)
  • How was recovery? (long recovery, with prolonged drowsiness and confusion suggests seizure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the management of falls?

A
  • Treat the underlying cause (often not found, multifactorial)
  • Drug review (reduce polypharmacy, reduce dose or stop medications that could contribute)
  • Treatment of orthostatic hypotension (advise to stand slowly, lie down at prodrome, fluid and salt replacement if needed, consider fludrocortisone or alpha-agonist)
  • Physiotherapy (strength and balance training, walking aids)
  • Occupational therapy (environmental assessment and modification)
  • Prevent adverse consequences (osteoporosis treatment, alarms, supervision, change of accommodation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Define osteoporosis

A

Reduction in the bone mass density and disruption of the bone architecture, due to a prolonged imbalance of bone remodelling where resorption exceeds deposition, resulting in increased bone fragility and fracture risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the risk factors for a fragility fracture?

A
  • Increasing age
  • Female
  • Low BMI
  • Parental history of hip fracture
  • Past history of fragility fractures
  • Corticosteroid therapy
  • Cushing’s syndrome
  • Alcohol intake of more than 3 units/day
  • Smoking
  • Conditions which increase falls risks (e.g. visual impairment, lack of neuromuscular co-ordination and strength, cognitive impairment, sedatives)
  • Secondary osteoporosis (rheumatoid arthritis, type 1 diabetes, premature menopause, chronic liver disease, IBD, coeliac, hyperthyroidism, hypogonadism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the clinical features of osteoporosis?

A
  • The pathological process itself is asymptomatic
  • Often presents with fragility fractures (e.g. wrist, femoral neck, vertebral body)
  • Wedging of the vertebrae caused by higher load bearing by the anterior potion of the vertebral body, presenting as acute painful fracture, progressive kyphosis, or incidental findings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the investigations for osteoporosis?

A
  • DEXA scan: gives T score which compare BMD to peak bone mass (<-2.5 indicated osteoporosis)
  • X-ray: shows fractures
  • Bloods: identify treatable cause and rule out other causes (FBC, CRP, U+Es, LFTs, TFTs, calcium, testosterone in men)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the management of osteoporosis?

A
  • Calcium and vitamin D supplements if required

Antiresorptive therapy…
- oral bisphosphonates: e.g. alendronate, once weekly, taken 30 minutes before food/drink remaining upright for 30 mins, SE of GI issues, CI in oesophageal issues and hypocalcaemia
- IV bisphosphonates: e.g. zoledronate, 1st line in hip fractures, given as yearly infusion, possible SE of acute phase reaction, CI in hypocalcaemia and severe renal impairment
- monoclonal antibodies: e.g. denosumab, given as s/c injection every 6 months, SE of skin reactions, hypocalcaemia

Anabolic therapy…
- teriparatide: recombinant PTH, 1st line in postmenopausal women or men >50 at very high risk, given as daily s/c injection, SE of nausea, dizziness, postural hypotension, CI in hypercalcaemia, severe renal impairment, bone malignancy, pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What factors support a diagnosis of normal aging rather than pathological cognitive decline?

A
  • Ability to maintain function in normal life through aids (e.g. lists, calendars), or adaptation (e.g. of the environment, of one’s expectations)
  • A very long time scale of decline (10-30 years, rather than months-short years)
  • A relative decline to the person’s previous cognition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Define dementia

A

A syndrome of generalised decline of memory, intellect and personality, without impairment of consciousness, leading to functional impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Describe the difference between delirium and dementia

A
  • Onset: delirium has an acute onset, dementia has a more chronic onset
  • Reversibility: delirium is often reversible, dementia is rarely reversible
  • Fluctuation: delirium can fluctuate hour-to hour or diurnal, dementia has little fluctuation but have have diurnal variation (sundowning)
  • Attention and conscious level: both are affected and variable in delirium, not affected in dementia unless severe
  • Hallucinations: common in delirium, usually occurs in late stages of dementia and more likely to be visual
  • Short and long term memory: both are poor in delirium, but long term memory is often normal until the late stages of dementia
30
Q

Describe some different types of dementia

A
  • Alzheimer’s disease: degeneration of cholinergic neurons leading to a deficiency of acetylcholine in the cerebral cortex, with changes including cortical atrophy, neurofibrillary tangles, amyloid plaque formation
  • Vascular dementia: damage from cerebrovascular disease due to a major stroke, multi-infarcts (smaller unrecognised strokes), or chronic changes to small vessels (arteriosclerosis)
  • Lewy-body dementia: abnormal deposition of a protein (Lewy body) within the neurons of the brain stem, neocortex, and substantia nigra
  • Fronto-temporal dementia: specific degeneration (atrophy) of the frontal and temporal lobes, with a specific type being Pick’s disease (deposition of protein tangles/Pick’s bodies)
  • Other causes of dementia include Parkinson’s, infections (syphilis, HIV, CJD), substance misuse, folate/B12 deficiencies, normal pressure hydrocephalus, space-occupying lesions
31
Q

What are the clinical features of Alzheimer’s disease?

A
  • most common type, insidious onset with slow progression over years
  • Loss of memory (commonest presenting symptom, first short then long-term)
  • Disorientation to time and place
  • Impaired executive functions (problem solving, abstract thinking, decision making, judgement, organisation, processing)
  • Language disturbance (word finding difficulties, decreased vocabulary, perseveration, global aphasia)
  • Apraxia (difficulty with previously learned purposeful movements e.g. dressing, buttons, despite normal coordination and strength)
  • Visuospatial abilities (getting lost, impaired driving)
  • Non-cognitive symptoms: (hallucinations, delusions, emotional changes, abnormal behaviour)
32
Q

What are the clinical features of vascular dementia?

A
  • associated with vascular risk factors (diabetes, hypertension, smoking)
  • Stepwise and abrupt deterioration of cognition (including memory, orientation, executive function, attention, language function)
  • Emotional and personality changes (depressions, apathy), earliest symptoms
  • Neurological symptoms (e.g. unilateral spastic weakness, increased tendon reflexes, focal upper motor neuron signs, abnormal gait, urinary incontinence, dysphagia)
33
Q

What are the clinical features of Lewy body dementia?

A
  • Background of gradually progressive dementia, with insidious onset
  • Day to day fluctuations in cognitive performance
  • Recurrent visual hallucinations, often with paranoia and delusions
  • Parkinsonism motor signs (tremor, rigidity, bradykinesia)
  • Severe sensitivity to typical antipsychotics and dopamine agonists, which worsen confusion and parkinsonism
34
Q

What are the clinical features of front-temporal dementia?

A
  • Usual insidious onset aged 35-75, with slow progression
  • Behavioural changes (e.g. disinhibition, inflexibility, apathy, repetitive behaviours/compulsions, impaired executive functions, decreased personal care, lack of insight)
  • Language impairment (e.g. loss of vocabulary, difficulty finding words, loosing meaning/recognition of words/objects, slow or hesitant speech, loss of literacy skills)
  • Memory and other cognitive impairments may only be affected in later stages
35
Q

Describe normal pressure hydrocephalus

A
  • Condition of ventricular dilatation in the absence of raised CSF pressure on lumbar puncture
  • May be idiopathic, or have a secondary cause (head injury, meningitis, subarachnoid haemorrhage, CNS tumour)
  • Presents with triad of gait disturbance (wide-based), urinary incontinence, cognitive impairment
  • Investigations: neuroimaging, lumbar puncture (normal opening pressure, remove CSF to check for improved symptoms)
  • Treated with CSF shunt (to peritoneum, right atrium, or external drainage)
36
Q

What investigations are needed for cognitive impairment?

A
  • Bloods: FBC (infection, anaemia), CRP (infection, inflammation), U&Es (renal disease), LFTs (liver disease), calcium (hypercalcaemia), glucose (hypoglycaemia), vitamin B12 and folate (nutritional deficiencies)
  • Urinalysis (UTI)
  • Chest X-ray (pneumonia, tumour)
  • Syphilis and HIV testing (only if specific risk)
  • Brain imaging (indicated in early/sudden onset, risk of structural pathology, focal CNS signs): CT (can identify cortical atrophy), MRI (identifies posterior circulation pathology), SPECT (only in specialist centres, differentiate between types)
  • EEG: if fronto-temporal dementia, CJD, or seizure activity is suspected
  • Lumbar puncture: if meningitis or CJD is suspected
  • Genetic testing: for Huntington’s or familial dementia
  • Cognitive assessment: MMSE, AMT, 4AT etc
37
Q

What is the management for dementia?

A

Non-pharmacological:
- social support (support groups)
- assistance with ADLs (OT, carers)
- information and education
- community services (meals-on-wheels, day centres, respite care)
- alternative therapies (aromatherapy, massage, music, art, animal)
- carers support

Pharmacological:
- Acetylcholinesterase inhibitors e.g. donepezil, rivastigmine (cognitive enhancers for Alzheimer’s and Lewy body dementia
- Memantine (N-methyl-D-aspartate receptor antagonist), for severe Alzheimer’s on where AChE inhibitors are not tolerated/contraindicated
- Management of behavioural changes: short course antipsychotics (not Lewy body dementia), antidepressants for low mood

38
Q

Define Parkinson’s disease

A

Parkinson’s disease is an idiopathic movement disorder associated characterised by a resting tremor, rigidity, and bradykinesia, caused by degeneration of the dopaminergic pathways in the substantia nigra

39
Q

What is the pathophysiology of Parkinson’s disease?

A

Loss of dopaminergic neurons in the substantia nigra, with presence of Lewy Bodies

40
Q

What are the clinical feature of Parkinson’s disease?

A
  • Tremor: worse at rest, pin-rolling movements
  • Rigidity: cogwheeling (due to tremor superimposed on rigidity)
  • Bradykinesia: slowness of voluntary movements, seen as reduced arm swinging, expressionless face, fatigability of repetitive movements
  • Gait disturbances: small shuffling steps, difficulty rising from sitting, difficulty turning/stopping
  • Postural instability: tendency to fall
  • Non-motor features: late autonomic features (weight loss, dysphagia, orthostatic hypotension, drooling, constipation), sleep disturbance, depression, psychosis (related to medications)
    • signs are initially unilateral, then become generalised
41
Q

What investigations are needed for Parkinson’s disease?

A
  • Diagnosis is clinical
  • Neuroimaging (CT/MRI): exclude other causes, if fails to respond to L-dopa
  • SPECT scan can assist diagnosis
42
Q

Describe Parkinson’s disease with dementia

A
  • Defined as dementia occurring more than one year after a diagnosis of Parkinson’s disease
  • Similar to Alzheimer-type dementia, but with Parkinsonism in the limbs and frequent hallucinations and fluctuations in lucidity
  • Difficult to treat as confusion and hallucination may be worsened by Parkinson’s medication
    • if Parkinsonism develops after dementia, this is Lewy body dementia
43
Q

What is the management for Parkinson’s disease?

A

Non-pharmacological:
- physio and OT
- speech and language therapy
- care package

Drugs for motor symptoms:
- levodopa (plus decarboxylase inhibitor, prevent breakdown of drug, e.g. Madopar)
- dopamine agonists (ropinirole, pergolide, cabergoline)
- monoamine oxidase-B inhibitors (selegiline, rasagiline
- catechol-O-methyltransferase inhibitors (inhibit peripheral breakdown of L-dopa, e.g. entacapone)

Drugs for non-motor symptoms:
- SSRI for depression
- cholinesterase inhibitors (rivastigmine) for dementia
- modafinil for daytime sleepiness
- midodrine or fludrocortisone for orthostatic hypotension

Surgery:
- deep brain stimulation

44
Q

Define heart failure

A

A clinical syndrome resulting in reduced cardiac output and/or elevated intracardiac pressures, characterised by classical signs/symptoms and objective evidence of a structural/functional abnormality

45
Q

Describe the classification of heart failure

A

Acute and chronic:
- describes time rather than severity
- acute heart failure can present as new-onset, or acute decomposition, managed as an inpatient
- chronic heart failure describes a long-standing condition managed in the community

Ejection fraction:
- describes the percentage of blood in the left ventricle which is pumped with each heartbeat, which determines severity
- reduced LVEF (HFrEF) = 40% or less, significant reduction in LV systolic function
- mildly reduced LVEF = 41-49%
- preserved ejection fraction (HFpEF) = 50% of higher

46
Q

Describe the New York Heart Association staging of heart failure

A
  • Class I: no physical limitation, ordinary activity does not cause fatigue, breathlessness, or palpitations
  • Class II: slight physical limitation, comfortable at rest but ordinary activity causes fatigue, breathlessness, or palpitations
  • Class III: marked physical limitation, comfortable at rest but less than ordinary activity causes fatigue, breathlessness, or palpitations
  • Class IV: unable to carry out physical activity without discomfort, symptoms present at rest
47
Q

What are the causes of heart failure?

A
  • Coronary heart disease (especially Caucasians)
  • Hypertension (especially African Caribbeans)
  • Valvular heart disease
  • Cardiomyopathies
  • Pericardial disease (pericarditis, effusion)
  • Arrhythmias
  • Conditions that increase peripheral demand (e.g. anaemia, pregnancy, hyperthyroid, Paget’s disease, sepsis)
48
Q

What are the clinical features of heart failure?

A

Symptoms:
- Exertional dyspnoea and fatigue (limits exercise tolerance)
- Orthopnoea
- Paroxysmal nocturnal dyspnoea
- Fluid retention (causing pulmonary or peripheral oedema
- Nocturnal cough or wheeze (+/- pink frothy sputum)
- Light-headedness or syncope
- Anorexia

Signs:
- tachycardia
- low systolic blood pressure
- narrow pulse pressure
- displaced apex beat
- gallop rhythm (presence of S3)
- raised JVP
- bilateral basal end-inspiratory crackles +/- wheeze
- tachypnoea
- pleural effusions
- tender hepatomegaly (pulsatile in tricuspid regurgitation)
- peripheral oedema (ankles, sacral, ascites)

49
Q

What investigations are needed for heart failure?

A
  • Routine bloods: FBC (anaemia), U&Es (renal function, electrolyte abnormalities in fluid overload, LFTs (hepatic congestion, troponin (recent MI), lipids/HbA1c (ischemic risk profile)
  • N-terminal pro-B-type natriuretic peptide (NT-proBNP): increased with pressure overload on heart (can be raised/reduced in other causes)
  • ECG: abnormal in most cases (AF, left axis deviation due to LVH, prolonged PR interval, wide QRS, abnormal P waves)
  • CXR: (ABCDE) alveolar oedema, Kerley B lines, cardiomegaly, dilated upper lobe vessel, pleural effusions
  • Echocardiography: for all patients with suspected heart failure, identifies ventricular dysfunction, valve disease, cardiomyopathy, estimates ejection fraction
50
Q

What is the management of heart failure?

A

Lifestyle changes:
- smoking cessation
- encourage good nutrition (low salt)
- avoid excessive alcohol
- weight loss if obese
- exercise (as part of supervised cardiac rehab)

Pharmacological:
- diuretics (loop diuretics e.g. furosemide for symptoms control, thiazide diuretics added in end stage)
- ACE inhibitors (e.g. ramipril, started in all patients, use ARB as an alternative)
- beta blockers (e.g. bisoprolol, started in all patients)
- spironolactone (for continuing symptoms despite diuretic and ACEi)
- SGLT2 inhibitor ( e.g. empagliflozin, for continuing symptoms despite other therapy)
- digoxin (for continuing symptoms despite other therapy in sinus rhythm)
- ivabradine (for continuing symptoms despite other therapy in sinus rhythm)
- DOAC/warfarin (for AF, or intracardiac thrombus on echo)
- statins (for secondary prevention where the cause is IHD)

51
Q

What is end-stage heart failure, and when is it suspected?

A
  • End-stage heart failure = high risk of dying within 6-12 months
  • Frequent hospital admissions
  • Poor response to treatment and severe breathlessness at rest
  • Acute deterioration and frequent admissions from comorbid conditions (e.g. chest infection)
  • Poor QOL and dependence on others for ADLs
  • Low serum albumin, deterioration in eGFR and hypotension
52
Q

What should an advanced care plan address?

A
  • Sensitive, open, and honest information on prognosis
  • The person’s preferences regarding location they wish to be cared for in and resuscitation status
  • Anticipatory prescribing of medication to manage symptoms
  • When, who, and how to call for help in a crisis or acute exacerbation
  • The needs for psychological and spiritual care
  • Care for the family (before and after the person’s death)
53
Q

What pre-emptive medications are used in end of life care?

A
  • Analgesia/dyspnoea: morphine (oxycodone in renal impairment)
  • Antisecretory: hyoscine (antimuscarinic)
  • Antiemetic: haloperidol
  • Sedative: midazolam (benzodiazepine)
54
Q

Describe malnutrition in the elderly

A
  • Normal aging includes reduced calorie requirements, reduction in appetite, and lower reserves of macro and micronutrients
  • Malnutrition therefore occurs quickly in the presence of disease, and nutritional status declines further if hospitalised
55
Q

How is nutrition assessed?

A
  • BMI (approximations can be made using ulnar length and mid-arm circumference
  • Screening tools (e.g. MUST)
  • Biochemical measurements (e.g. anaemia, hypoalbuminaemia, hypocholesterolaemia)
56
Q

What does nutritional support involve?

A
  • Early identification and involvement of MDT including dietician
  • Record food intake
  • Prioritise mealtimes (protected times, provide assistance)
  • Establish food preferences and offer high-calorie foods
  • Prescribe dietary supplements according to patient preferences (e.g. milky/fruity drinks, soups, yogurts, puddings)
  • Consider role of enteral feeding
57
Q

Describe enteral feeding

A
  • Considered if there is dysphagia (e.g. stroke, MND) or failure of oral feeding (anorexia, ICU) with a functioning GI tract
  • Common methods are NG tube (preferred short term but risks of self-removal), PEG (more complicated insertion, but better tolerated and discrete)
  • Complications include aspiration pneumonia, refeeding syndrome, fluid overload, diarrhoea
58
Q

Define constipation

A

The term constipation can be used to describe one or more of…
- the time between bowel evacuations being longer than normal
- the stool being harder, dryer, or smaller than normal
- an increase of total faecal mass within the abdomen

59
Q

Describe parenteral feeding

A
  • Consider when the gut is not functioning, usually as a temporary measure
  • Requires central venous access, and only under supervision of specialist nutritional team
  • Complications include fluid overload, electrolyte disturbance, IV catheter sepsis
60
Q

What are the causes of constipation in the elderly?

A

Reduced bowel motility:
- drugs (opiates, iron, anticholinergics, antidepressants, calcium channel blockers)
- immobility
- electrolyte disturbances (hypercalcaemia, hypokalaemia)
- hypothyroidism
- dehydration
- lack of fibre

Failure to evacuate bowels fully:
- anorectal disease (haemorrhoids, fissure, stricture, prolapse)
- difficulty accessing toilet
- post operative pain
- lack of privacy
- altered daily routine

Neuromuscular:
- Parkinson’s disease
- diabetic neuropathy
- spinal or pelvic nerve injury

Mechanical obstruction:
- malignancy
- diverticular disease
- pelvic mass (e.g. fibroids)
- pseudo-obstruction

61
Q

How is constipation assessed?

A
  • Suspect in elderly patients presenting with confusion, nausea, loss of appetite, overflow diarrhoea, urinary retention
  • Rectal examination may be diagnostic, but empty rectum may indicate high impaction (confirmed with adnominal X-ray)
  • Investigations needed if age >40, recent change in bowel habit, associated symptoms (FBC, U&E, Ca, TFTs, sigmoidoscopy)
62
Q

How is constipation managed?

A

Supportive management:
- treat cause
- mobilise patient
- increase fluid intake
- increase intake of high-fibre foods (fruit, veg, whole wheat, bran)
- improve access to toilet

Drug therapy:
- bulking agents (bran powder, ispaghula husk, methylcellulose)
- osmotic agents (macrogols, lactulose, laxido)
- stimulants (oral - senna, bisacodyl, suppositories - bisacodyl, glycerol, enemas - docusate sodium, sodium phosphate,
- stool softeners (arachis oil enema)

63
Q

Define pressure sores

A

Skin damage occurring due to pressure-induced ischemia, presenting as red, blistered, broken, or necrotic areas that may extend to underlying structures

64
Q

What are the risk factors for pressure sores?

A
  • Older age
  • Immobility (especially postoperatively)
  • Low or high body wight
  • Malnutrition
  • Dehydration
  • Incontinence
  • Decreased consciousness
  • Cognitive impairment
  • Neuropathy
  • Vascular impairment
  • Peripheral oedema
65
Q

Describe the grading of pressure sores

A
  • 0: skin hyperaemia (redness)
  • 1: non-blanching erythema of intact skin
  • 2: partial-thickness skin loss (epidermis +/- dermis)
  • 3: full-thickness skin loss (down to subcutaneous fat
  • 4: tissue necrosis and ulceration down to muscle/bone
66
Q

What is the management of pressure sores?

A
  • Mobility and positioning (encourage mobilising, reposition regularly, avoid direct pressure)
  • Pressure relief (high specification foam/alternating pressure mattresses, cushions)
  • Wound management (wound dressings and topical treatments)
  • Promote healing (good nutrition, glycaemic control, manage incontinence)
  • Pain relief
  • Infection control (antibiotics needed if signs of cellulitis or sepsis)
  • Debridement (removal of necrotic tissue, can be autolytic using bodies own enzymes, or surgical)
67
Q

Define rhabdomyolysis

A

A clinical syndrome associated with the breakdown of skeletal muscle and release of myoglobin which is nephrotoxic in high levels, causing acute renal failure

68
Q

What are the causes of rhabdomyolysis?

A

Anything that leads to muscle necrosis:
- trauma
- significant prolonged pressure (e.g. long lie after fall)
- burns
- compartment syndrome
- alcohol misuse
- over exertion
- status epilepticus
- heat stroke
- neuroleptic malignant syndrome
- drugs (e.g. statins)

69
Q

What are the clinical features of rhabdomyolysis?

A
  • Non-specific (e.g. fever, malaise, nausea, vomiting, anorexia)
  • Muscle pain and weakness
  • Signs of clinical dehydration
  • Confusion, agitation, delirium (in elderly)
  • Dark urine
70
Q

What investigations are needed for rhabdomyolysis?

A
  • CK levels: raised at least 5 times normal
  • Potassium: raised
  • Calcium: low
  • Urine dipstick: positive for blood (haemoglobin present, but no RBCs)
71
Q

What is the management of rhabdomyolysis?

A
  • Aggressive rehydration (with monitoring of urine output and renal function)
  • Treat hyperkalaemia (calcium gluconate and dextrose-insulin infusion)
  • Haemodialysis if renal failure